pirazolilaminopiridinas como inibidores da fak

The present invention relates to a compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R11, R12, R13, Q, Z, and p are as described herein. Compounds of the present invention are useful for the treatment of cancers.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MARK MELLINGER, THOMAS H. FAITG, JIRI KASPAREC, REN XIE, HONG LIN, XIN PENG, NEIL W. JOHNSON, JERRY LEROY ADAMS
Format: Patent
Sprache:por
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to a compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R11, R12, R13, Q, Z, and p are as described herein. Compounds of the present invention are useful for the treatment of cancers.